Keyphrases
Endothelial Cells
100%
Vascular Endothelial Growth Factor Receptor (VEGFR)
100%
Epidermal Growth Factor Receptor Transactivation
100%
Protease-activated Receptor 2 (PAR2)
100%
Preeclampsia
37%
Protein Kinase
25%
Human Umbilical Vein Endothelial Cells (HUVECs)
25%
Heme oxygenase-1 (HO-1)
25%
Overexpression
12%
Epidermal Growth Factor Receptor
12%
Inflammatory Cytokines
12%
Simvastatin
12%
Mitogen-activated Protein Kinase
12%
Kinase Activation
12%
Cell-derived
12%
Serine Proteinase
12%
Dominant-negative mutant
12%
Small Interfering RNA (siRNA)
12%
Putative Drug Targets
12%
Receptor 1
12%
Endothelial Damage
12%
Gaseous Products
12%
Carbon Dioxide
12%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
12%
SLIGRL
12%
Maternal Vascular
12%
Maternal Circulation
12%
Factor Xa
12%
Blood Coagulation
12%
Transactivation
12%
Vascular Dysfunction
12%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Transactivation
100%
VEGF Receptors
100%
Protease-Activated Receptor 2
100%
calcium activated,phospholipid dependent protein kinase
33%
Heme Oxygenase
33%
Enzyme
16%
extracellular signal regulated kinase
16%
Coagulation System
16%
Serine Protease
16%
Proinflammatory Cytokine
16%
Small Interfering RNA
16%
Prothrombinase
16%
Simvastatin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Vasculotropin Receptor 1
100%
Proteinase Activated Receptor 2
100%
Preeclampsia
50%
calcium activated,phospholipid dependent protein kinase
33%
Heme Oxygenase 1
33%
Cytokine
16%
Simvastatin
16%
Mitogen Activated Protein Kinase
16%
Small Interfering RNA
16%
Serine Proteinase
16%
Carbon Monoxide
16%
Blood Clotting Factor 10a
16%